You searched for "screening"
KARL STORZ Endoscopic Ear Surgery Set
Marcus Brechtold, Senior Director of Product Management – Oto-Rhino-Laryngology, OMFS, Spine and Neurosurgery at KARL STORZ GMBH & Co. KG, tells EES Guest Editor, Chris Coulson, about the company’s new Endoscopic Ear Surgery Set, developed in collaboration with the International...The future of head and neck cancer surgery
Neil Sharma paints an exciting picture of the future of head and neck surgery with nanobots and robot augmented humans – science fiction or reality? Time will tell. ‘May you live in interesting times’ reads the old Chinese curse. The...The challenges in the risk stratification of thyroid nodules and cancers: the role of molecular testing
Around the world, molecular testing is becoming more widely used to personalise the management of thyroid nodules. Thyroid nodules are relatively common. They are palpable in ~5% of the population, while high-resolution ultrasound (US) incidentally finds them in 19–68% of...Are you ready? How audiologists’ readiness for change relates to the implementation of remote care
Are we ready to deliver remote care? A question many of us have asked ourselves over the last year. Danielle Glista (Associate Professor, Western University) and colleagues talk through a systematic approach to implementing remote audiological care and suggest gaps...From the editor Sep/Oct 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk This edition marks a milestone for me, as it is exactly 10 years since I started as editor of...5th Annual Inner Ear Disorders Therapeutics Summit
Coined by industry as the only meeting of its kind and uniquely positioned to share fresh ideas and assess viable approaches to your most pressing preclinical, translational, and clinical bottlenecks, the 5th Inner Ear Disorders Summit returns as a forum to benchmark learnings from past failures, reignite momentum and develop investment into the audiology therapeutic landscape.COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...Translating research – transforming lives: the BACO 2020 academic programme
The main attraction of any conference or event is, of course, the academic programme of lectures, workshops and education. Hisham Mehanna, BACO 2020 Academic Chair, and Paul Nankivell, Academic Vice Chair, give us an overview of what to expected in...
